THURSDAY, Feb. 13, 2020 (HealthDay News) — A clinical trial of the weight-loss drug Belviq (lorcaserin) shows an association with an increased risk of cancer, and the U.S. Food and Drug Administration is requesting that its maker withdraw the drug from the U.S. market. Eisai Inc. has already “submitted aContinue Reading
THURSDAY, Feb. 13, 2020 (HealthDay News) — While fewer Americans are smoking these days, the habit has remained stubbornly persistent among stroke survivors, new research shows. The researchers found that the prevalence of smoking among U.S. stroke survivors has not improved since 1999 and, as of 2016, stood at 26%.Continue Reading
X1-5 Hoverboards Pose Fire Risk
Some Coronavirus Testing Kits Sent to States Are Faulty: CDC
Labeling Error Led to Release of Woman Infected with Coronavirus: U.S. Officials
Continue Reading
WEDNESDAY, Feb. 12, 2020 (HealthDay News) — Researchers who have pinpointed an antibody linked to life-threatening autoimmune disorders in children say their discovery could lead to faster diagnosis and treatment of these patients. The investigators identified the myelin oligodendrocyte glycoprotein (MOG) antibody in their study of 535 children with centralContinue Reading
WEDNESDAY, Feb. 12, 2020 (HealthDay News) — A deadly virus that’s surging through a foreign country makes its way into the United States, carried into this country by an unwitting traveler. In response, Americans panic, convinced the pathogen will soon sweep through the nation — even though only a handfulContinue Reading
TUESDAY, Feb. 11, 2020 (HealthDay News) — Getting your surly teens off the couch might trigger a long-term turnaround in their moods, new research suggests. “Our findings show that young people who are inactive for large proportions of the day throughout adolescence face a greater risk of depression by ageContinue Reading
MONDAY, Feb. 10, 2020 (HealthDay News) — In the midst of a U.S. epidemic of opioid abuse, knowing how to quickly administer the anti-overdose drug naloxone could save a life. Now, research finds that delivering naloxone via nasal spray could be the quickest and easiest of three methods of administration.Continue Reading
MONDAY, Feb. 10, 2020 (HealthDay News) — Two experimental drugs do not appear to slow memory loss or mental decline in patients in the early stages of a rare, inherited form of Alzheimer’s disease, according to initial results from a clinical trial. The international phase 2 and 3 clinical trialContinue Reading
MONDAY, Feb. 10, 2020 (HealthDay News) — Migraine drugs that might work for adults won’t prevent the debilitating headaches in kids and teens, a new study shows. A number of drugs are used to prevent migraines, but treatment of youngsters has largely been based on the results of adult studies,Continue Reading